This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page


    Page   1/2   
  • 2013 Global life sciences outlook
    Optimism tempered by reality in a “new normal”
  • mHealth in an mWorld
    How mobile technology is transforming health care
  • Primary Care: Today and Tomorrow - Improving general practice by working differently
    New Directions - Innovation that drives quality
  • Telecare and Telehealth
    A game changer for health and social care
  • Health care reform and life sciences: Threat, opportunity or both?
    Changing innovation processes and sales models crucial for companies to get ahead
  • Big Pharma
    Business model choices for the new market
  • Life Sciences: Accounting and Financial Reporting Update (March 2013)
    This publication highlights specialized accounting and reporting considerations applicable to companies in this industry.
  • Transformation beyond reform
    Explore key topics from the Financial Times U.S. Healthcare and Life Sciences Conference, held 6 June 2013.
  • 2014 Global health care sector outlook
    Shared challenges, shared opportunties
  • Measuring the return from innovation
    Is R&D earning its investment?
  • Page   1/2   
Material on this website is © 2014 Deloitte Global Services Limited, or a member firm of Deloitte Touche Tohmatsu Limited, or one of their affiliates. See Legal for copyright and other legal information.

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. Please see “About Deloitte” for a more detailed description of DTTL and its member firms.

Get connected
Share your comments


More on Deloitte
Learn about our site